New stent shows promise for clot removal in stroke patients

NCT ID NCT04973332

Completed Disease control Sponsor: Sinomed Neurovita Technology Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a new stent (SINOMED SR) for removing blood clots in 218 people with acute ischemic stroke. The stent was used within 24 hours of symptom onset. The main goal was to see if the stent could successfully reopen blocked brain arteries. Researchers also tracked how well patients recovered 90 days later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intracranial thrombectomy stent (SINOMED SR)
What this could lead to: If successful, this stent could provide a safe and effective option for removing blood clots in stroke patients within 24 hours of symptoms, potentially improving recovery.
What could go wrong: This is a non-inferiority study, meaning it aims to show the new stent is as good as existing ones, not necessarily better. The trial is completed but results may not apply to all stroke types or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain disorder cerebrovascular disorder ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN DISEASES CEREBROVASCULAR DISORDERS ISCHEMIC STROKE, ACUTE

Contacts and locations

Locations

Central Hospital of Xiang Tan city

Xiangtan, China
Ganzhou Municipal Hospital

Ganzhou, China
Ganzhou People's Hospital

Ganzhou, China
General Hospital of Eastern Theater Command, PLA

Nanjing, 210000, China
General Hospital of Northern Theater Command, PLA

Shenyang, China
Handan Central Hospital

Handan, China
Jiangmen Wuyi Hospital of Traditional Chinese Medicine

Jiangmen, China
Jinan Central Hospital

Jinan, China
Meizhou People's Hospital

Meizhou, China
Qingdao Center Hospital

Qingdao, China
Taiyuan Central Hospital

Taiyuan, China
The First Affiliated Hospital of Nanchang University

Nanchang, China
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Hehui, China
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)

Wuhu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.